# Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

> **NCT00519844** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 5 (actual)

## Conditions studied

- Foetal Growth Problem
- Small for Gestational Age

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00519844
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519844, "Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00519844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*